Invictus MD Strategies (Invictus MD Strategies) EV-to-EBITDA : 0.00 (As of Apr. 27, 2024)

Invictus MD Strategies EV-to-EBITDA Chart

Invictus MD Strategies Quarterly Data
	Jan15	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19
EV-to-EBITDA	Get a 7-Day Free Trial															-4.82	-4.50	-3.04	-1.63	-0.85

Competitive Comparison of Invictus MD Strategies's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invictus MD Strategies's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's EV-to-EBITDA falls into.

Invictus MD Strategies EV-to-EBITDA Calculation

Invictus MD Strategies's EV-to-EBITDA for today is calculated as:

Invictus MD Strategies's current Enterprise Value is $0.00 Mil.
Invictus MD Strategies's EBITDA for the trailing twelve months (TTM) ended in Oct. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invictus MD Strategies  (OTCPK:IVITF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Invictus MD Strategies's PE Ratio for today is calculated as:

Invictus MD Strategies's share price for today is $0.0001.
Invictus MD Strategies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.242.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Invictus MD Strategies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Invictus MD Strategies (Invictus MD Strategies) Business Description